Bicocca Open Archive

Logo unimib boa
MANTOVANI, LORENZO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.682
AS - Asia 24.608
EU - Europa 19.122
SA - Sud America 3.409
AF - Africa 597
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 40
Totale 83.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.417
SG - Singapore 9.110
IT - Italia 6.352
CN - Cina 4.529
HK - Hong Kong 3.506
VN - Vietnam 3.391
RU - Federazione Russa 2.922
BR - Brasile 2.586
DE - Germania 2.199
CA - Canada 1.910
IE - Irlanda 1.553
SE - Svezia 1.462
FR - Francia 968
GB - Regno Unito 892
UA - Ucraina 779
BD - Bangladesh 772
IN - India 710
FI - Finlandia 457
ID - Indonesia 439
AR - Argentina 306
NL - Olanda 301
AT - Austria 290
TR - Turchia 287
KR - Corea 266
IQ - Iraq 246
MX - Messico 197
DK - Danimarca 190
JP - Giappone 187
PK - Pakistan 186
ZA - Sudafrica 177
ES - Italia 153
SA - Arabia Saudita 139
PH - Filippine 132
PL - Polonia 127
EC - Ecuador 111
VE - Venezuela 98
CH - Svizzera 97
UZ - Uzbekistan 89
CO - Colombia 88
MA - Marocco 88
IR - Iran 81
AU - Australia 71
MY - Malesia 68
CL - Cile 65
BE - Belgio 62
AE - Emirati Arabi Uniti 56
EG - Egitto 54
PY - Paraguay 54
JO - Giordania 53
KE - Kenya 53
TH - Thailandia 48
TN - Tunisia 47
ET - Etiopia 44
JM - Giamaica 40
RO - Romania 40
CZ - Repubblica Ceca 38
NP - Nepal 38
UY - Uruguay 35
PE - Perù 34
TW - Taiwan 32
DZ - Algeria 30
EU - Europa 30
OM - Oman 28
AL - Albania 27
BO - Bolivia 27
PT - Portogallo 27
LB - Libano 24
NG - Nigeria 23
IL - Israele 22
RS - Serbia 22
AZ - Azerbaigian 21
BG - Bulgaria 19
CR - Costa Rica 19
KZ - Kazakistan 19
LT - Lituania 19
GR - Grecia 17
HN - Honduras 16
KG - Kirghizistan 16
SN - Senegal 16
NI - Nicaragua 15
HU - Ungheria 14
LK - Sri Lanka 14
MD - Moldavia 14
PS - Palestinian Territory 14
GT - Guatemala 13
NO - Norvegia 13
QA - Qatar 13
SI - Slovenia 13
BH - Bahrain 12
DO - Repubblica Dominicana 12
TT - Trinidad e Tobago 12
BY - Bielorussia 11
HR - Croazia 11
MN - Mongolia 11
NZ - Nuova Zelanda 11
GE - Georgia 10
KW - Kuwait 9
PA - Panama 8
LV - Lettonia 7
AO - Angola 6
Totale 83.387
Salva come PNG Salva come JPEG
Città #
Singapore 4.773
Ann Arbor 3.738
Hong Kong 3.449
Ashburn 2.912
San Jose 2.421
Fairfield 1.959
Milan 1.802
Woodbridge 1.679
Toronto 1.499
Dublin 1.448
Chandler 1.435
Frankfurt am Main 1.285
Houston 1.269
Wilmington 1.179
Santa Clara 1.150
New York 1.035
Ho Chi Minh City 1.005
Seattle 880
Hanoi 832
Beijing 749
Jacksonville 745
Princeton 668
Cambridge 662
Chicago 652
Dearborn 640
The Dalles 594
Los Angeles 586
Dallas 553
Rome 494
Hefei 399
Council Bluffs 398
Lauterbourg 367
Jakarta 324
Altamura 302
Lawrence 293
Moscow 292
São Paulo 271
Nanjing 270
Boardman 246
Helsinki 245
Seoul 235
Buffalo 228
Vienna 213
Shanghai 198
Hangzhou 156
San Diego 156
Guangzhou 155
London 155
Orem 151
Munich 145
Nuremberg 139
Tokyo 139
Da Nang 134
Columbus 119
Haiphong 117
Lachine 104
Shenyang 103
Andover 100
Dong Ket 100
Nanchang 98
Rio de Janeiro 92
Baghdad 88
Turin 88
Saint Petersburg 87
Bologna 83
Naples 82
Jinan 79
Fremont 76
Tashkent 76
Tianjin 76
Changsha 75
Salt Lake City 75
Warsaw 75
Brooklyn 74
Lappeenranta 74
Washington 74
Chennai 70
Dhaka 70
Hebei 70
Montreal 70
Denver 63
Menlo Park 63
Zurich 63
Johannesburg 62
Phoenix 62
Norwalk 60
Zhengzhou 60
Atlanta 59
Jiaxing 58
Ninh Bình 58
Biên Hòa 57
Brasília 57
Mexico City 57
Ottawa 56
Amsterdam 55
Boston 55
Florence 55
Mumbai 55
Falls Church 53
Figino 53
Totale 51.160
Salva come PNG Salva come JPEG
Nome #
Costi dell’infarto miocardico acuto: analisi di dati sanitari amministrativi 973
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 580
Epidemiology of SLE in Italy: an observational study using a primary care database 554
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings from 2010 to 2019 537
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 477
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry 468
Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population 466
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 459
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 459
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 452
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review 437
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors 433
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study 424
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 412
Distribution of Malocclusion Traits in the Pediatric Population of Milan: An Observational Study 405
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 394
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 388
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 381
Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation 380
Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 375
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 374
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 372
Inflammatory bowel diseases in italy: incidence trends and patients’ characteristics 367
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 365
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 364
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 363
Use of health care administrative databases to estimate the burden of breast cancer. 361
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 358
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 357
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 357
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 353
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 347
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 346
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study) 345
Utilization, Outcomes and Costs of Implantable Cardioverter Defibrillators in Italy: A Population-Based Analysis Using Healthcare Administrative Databases 342
Health related quality of life in chronic liver diseases 340
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 334
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 334
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 324
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 323
The socioeconomic burden of patients affected by hemophilia with inhibitors 323
Costs and effectiveness of influenza vaccination: A systematic review 320
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 316
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 313
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 310
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 305
The impact of liver disease on the health-related quality of life 305
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 304
Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016 301
Impatto clinico ed economico della gestione dei rialzi pressori in gravidanza in regime di pronto soccorso: il possibile ruolo dei marcatori biochimici 296
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 296
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 295
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 292
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 291
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 290
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 289
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 289
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 289
Treatment of venous thromboembolism with tinzaparin in oncological patients 287
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 286
Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy 284
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 283
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 282
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 282
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 281
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 280
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 279
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 277
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 277
Sustainability of the Italian National Health Service 277
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 276
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 276
The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities 276
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 275
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 273
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015 273
Difference in health related quality of life of chronic liver diseases and general population 271
Health Related Quality of Life in the Major Liver Conditions 270
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 270
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry 269
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 268
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 265
Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016 265
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 264
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 263
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 262
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 260
Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions 257
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis 256
COVID-19 and Obesity: Is Bariatric Surgery Protective? Retrospective Analysis on 2145 Patients Undergone Bariatric-Metabolic Surgery from High Volume Center in Italy (Lombardy) 255
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 255
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 254
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 254
Medical Costs And Resources Consumption In Patients With Atrial Fibrillation: An Italian Observational Study 254
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 253
The economic impact of air pollution: a European assessment 253
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 252
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 252
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 252
Persistence and adherence to hypolipemic therapy in real practice: Results of a large administrative database 250
Totale 33.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 291.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 291.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.998 321 391 400 360 275 301 196 248 234 295 280 697
2022/20236.447 781 1.873 536 518 455 977 74 355 480 93 182 123
2023/20245.455 171 247 185 271 681 1.299 859 195 525 158 235 629
2024/202515.484 811 1.811 751 740 1.251 943 818 477 1.648 1.911 1.570 2.753
2025/202635.238 3.810 2.017 2.264 2.971 3.467 1.863 4.848 1.550 2.687 3.356 2.982 3.423
2026/2027152 152 0 0 0 0 0 0 0 0 0 0 0
Totale 85.895